tiprankstipranks
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
Holding STOK?
Track your performance easily

Stoke Therapeutics (STOK) Income Statement

339 Followers

Stoke Therapeutics Income Statement

Last quarter (Q3 2024), Stoke Therapeutics's total revenue was $4.89M, an increase of 47.94% from the same quarter last year. In Q3, Stoke Therapeutics's net income was $-26.43M. See Stoke Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 16.74M$ 8.78M$ 12.40M---
Cost of Revenue
------
Gross Profit
$ 16.74M$ 8.78M$ 12.40M---
Operating Expense
$ 134.05M$ 123.55M$ 116.76M$ 86.06M$ 53.04M$ -35.68M
Operating Income
$ -117.30M$ -114.77M$ -104.36M$ -86.06M$ -53.04M$ -35.68M
Net Non Operating Interest Income Expense
$ 12.25M$ 9.91M$ 3.12M$ 120.00K$ 700.00K$ 3.35M
Other Income Expense
$ 738.00K$ 166.00K$ 167.00K$ -140.00K$ -101.00K$ -2.00K
Pretax Income
$ -105.46M$ -104.70M$ -101.07M$ -85.81M$ -52.24M$ -32.33M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -105.46M$ -104.70M$ -101.07M$ -85.81M$ -52.24M$ -32.33M
Basic EPS
$ -2.11$ -2.38$ -2.60$ -2.34$ -1.56-
Diluted EPS
$ -2.11$ -2.38$ -2.60$ -2.34$ -1.56$ -1.80
Basic Average Shares
$ 203.34M$ 43.99M$ 38.90M$ 36.74M$ 33.49M$ 17.97M
Diluted Average Shares
$ 203.34M$ 43.99M$ 38.90M-$ 33.49M$ 17.96M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 134.05M$ 123.55M$ 116.76M$ 86.06M$ 53.04M$ -35.68M
Net Income From Continuing And Discontinued Operation
$ -105.46M$ -104.70M$ -101.07M$ -85.81M$ -52.24M$ -32.33M
Normalized Income
$ -99.01M$ -82.71M-$ -67.79M--
Interest Expense
------
EBIT
$ -111.66M$ -114.77M$ -104.36M$ -86.06M$ -53.04M$ -32.33M
EBITDA
$ -109.70M$ -112.30M$ -102.81M$ -85.09M$ -52.16M$ -31.88M
Currency in USD

Stoke Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis